NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver zapping may supercharge lung cancer treatment
Disease control Recruiting nowThis study looks at whether adding a precise radiation dose to liver tumors can make standard immunotherapy work better for people with stage IV non-small cell lung cancer. About 68 adults whose cancer has spread to the liver will either get standard drug therapy alone or standar…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
New hope for advanced lung cancer: experimental drug takes on chemo in major trial
Disease control Recruiting nowThis study compares an experimental drug (PF-08046054) to standard chemotherapy (docetaxel) in about 680 adults with advanced PD-L1 positive non-small cell lung cancer that has worsened after prior treatments. Participants are randomly assigned to receive one of the two drugs by …
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New combo aims to boost lung cancer treatment
Disease control Recruiting nowThis early-phase trial is testing whether adding the experimental drug binimetinib to the immunotherapy pembrolizumab (Keytruda) helps people with advanced non-small cell lung cancer. About 40 participants with high PD-L1 levels will receive the combination. The study aims to fin…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
New MET inhibitor DO-2 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called DO-2 in people with advanced solid tumors (like lung cancer) that have a specific genetic change (MET mutation) and have run out of standard treatments. The main goal is to check the drug's safety and how the body processes it. …
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Step up recovery: telecoaching aims to boost activity after lung cancer surgery
Symptom relief Recruiting nowThis study tests a 12-week home-based coaching program for people who had surgery for early-stage lung cancer. Participants wear a Fitbit and get personalized step goals and coach calls to help them move more. The goal is to see if this support improves daily physical activity co…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 18, 2026 11:53 UTC